The nation of Zimbabwe has declined a significant US health deal worth $367m (£272m) over five years because of the United States' demand for sensitive information.
The decision came to light after a government memo dated December was disclosed, indicating that President Emmerson Mnangagwa believed the deal was "lopsided".
An official spokesperson later explained that the United States was requesting biological samples for scientific study and profit while refused to guarantee the benefits from any future treatments.
"We will now turn to the challenging and unfortunate task of scaling back our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had provided over $1.9bn in health funding to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has appealed for further negotiations to secure a deal suitable to all parties so the nation's critical HIV programme can be sustained.
Broader Context
Zimbabwe's decision follows a comparable case in neighbouring Kenya, where a high court suspended a related health funding agreement following legal challenges were filed about the safety of Kenyans' medical information.
After returning to office last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
The agency had overseen assistance for the US government, but Trump claimed its spending was "wasteful" and his administration was seeking direct bilateral deals to enhance openness and responsibility.
According to reports, Sixteen African countries have to date signed similar agreements, representing over $18.3bn in committed funds.
Details of the Rejected Deal
This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership would have delivered immense benefits for Zimbabwean communities, especially the 1.2 million currently receiving HIV treatment via American-funded initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".
"Zimbabwe was being asked to share its genetic material and health information for a long time, without any corresponding assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.
"Effectively, our country would provide the raw materials for scientific discovery with no certainty that the final treatments would be accessible to our population if a new pandemic arise."
Sovereignty and Global Health
He also said that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were disrupting frameworks already set up through the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to deal with future global health emergencies.
"This system is intended to ensure that when a nation provides its information, the benefits – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We encourage continued discussions with our US partners on how future co-operation might be designed in a way that respects the sovereignty and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but recommended that talks need to persist since a large portion of the nation's HIV programmes depended on international support.
"If technical issues arise, including those relating to information security or agreement terms, these can often be addressed through technical clarification and negotiated safeguards," the group said.
The halted deal highlights the complex debate between accepting vital foreign assistance and safeguarding a country's data in an increasingly interconnected world.